Arcellx Inc
Biotechnology
Healthcare
ACLX
53.82 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
52.20
52 week high
106.53
high
59.82
52 week low
50.78
low
49.42
growth
13.77 %
previous Close
53.60
P/E ratio
market cap
4.08 B
div yield
0
usd
Sep 2024
qoq
revenue
26.03 M
-4.94 %
net incoming
-25.87 M
4.91 %
eps
0.00 %
5.88 %
eps surprise
-96.16 %
net profit margin
-99.37 %
-0.03 %
operating incoming
-33.62 M
3.94 %
net change in cash
61.82 M
213.33 %
cash on hand
162 M
61.47 %
cost of revenue
0.00 %
top top